
APDN Acquires Spindle Biotech, Launches LineaIVT™ Platform
July 13th, 2023
APDN Acquires Spindle Biotech, Launches LineaIVT™ Platform
July 13th, 2023
APDN to Present at Upcoming Healthcare Investor Conference
June 8th, 2023
Applied DNA Reports Second Quarter Fiscal 2023 Financial Results and Provides Corporate Update
May 11th, 2023
APDN to Report FQ2’23 Financial Results; Investor Conference Call/Webcast 5/11
May 3rd, 2023
CertainT® Featured in NY Times Re: Need for Transparency and Compliance
April 7th, 2023
APDN Milestone: Largest Single Large-Scale linearDNA™ Shipment to Date
March 29th, 2023
APDN Submits Validation Package to NYS DOH for Approval of PGx Assay
March 22nd, 2023
Applied DNA Reports First Quarter Fiscal 2023 Financial Results
February 9th, 2023
APDN to Report Q1 FY’23 Financial Results; Investor Conference Call/Webcast 2/9
February 2nd, 2023